“The entire industry deserves an opportunity to be heard before any major changes in rules are made—particularly those that will benefit the largest businesses.”
In testimony to joint cannabis committee, IG Jeffrey Shapiro explains reasons for proposed agency takeover, lays out potential path to receivership through legislature
Letter from Institute of Cannabis Science to lawmakers notes: “Our findings … show that fraudulent and harmful products reach consumers in Massachusetts.”
“Day-to-day operations need to be controlled and there needs to be clarity as to who is running the operation.” Shapiro will testify before joint cannabis committee on Tuesday.
The question on decriminalizing some psychedelics as a therapeutic option has flown under the radar
And one lawmaker decries deception but vows to “continue to work with grassroots advocates, veterans, mental health professionals, addiction specialists and a growing coalition of supporters”
“We are prepared to work with the Legislature and fellow appointing authorities on the path forward.”
Veteran impersonation act outrages activists, further muddies grassroots waters
At one point during Thursday’s meeting, Commissioner Roy read a letter from the CCC’s chief of research saying, “We don’t need an agency fighting with each other.”
“We hope that we can work with those who testified today to solve this issue, but we realize that a well-thought-out solution will require continued conversations into the next
